Every 10-Q that Acadia Healthcare Company, Inc. (ACHC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ACHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ACHC filings page.
Acadia Healthcare Company, Inc. reported second-quarter 2026 revenue of 865,839 (in thousands), essentially flat versus the prior-year quarter, while net income attributable to the company declined to 10,928 (in thousands) and basic earnings per share were $0.12. For the first six months of 2026, revenue was 1,694,641 (in thousands) and net income attributable to the company was 15,033 (in thousands), down from 38,501 (in thousands) a year earlier.
Profitability was pressured by higher operating costs, a 7,364 (in thousands) non-cash property impairment charge, an unfavorable 28,600 (in thousands) actuarial adjustment to self-insured professional and general liability reserves, and 13,800 (in thousands) of Sandoval legal settlement expense not covered by excess insurance. Transaction, legal and other costs were 44,592 (in thousands) for the first half, including 19,893 (in thousands) related to government investigations and other litigation. The effective tax rate rose to 49.3% for the six-month period, driven by nondeductible legal settlements and higher valuation allowances.
Operating cash flow strengthened to 223,598 (in thousands) for the first six months of 2026, while capital expenditures fell to 115,117 (in thousands), supporting a cash balance of 171,290 (in thousands) at June 30, 2026. Long-term debt was 2,382,069 (in thousands), with 669.8 million of revolving credit availability, and the company remained in compliance with financial covenants. Acadia operated 279 facilities with approximately 12,600 beds across 40 states and Puerto Rico.
Acadia Healthcare reported first-quarter 2026 revenue of $828.8 million, up 7.6% from $770.5 million a year earlier, driven by higher same-facility volumes and pricing. Medicaid represented 60.7% of revenue, reflecting the company’s focus on publicly funded behavioral health services.
Net income attributable to Acadia fell to $4.1 million, or $0.05 per diluted share, compared with $8.4 million and $0.09 a year earlier, as higher interest expense and legal-related costs weighed on results. Legal settlements expense rose to $13.8 million, mainly from an agreement in principle to resolve the Sandoval wrongful death litigation.
Operating cash flow strengthened to $61.5 million from $11.5 million, helped by working-capital improvements, while cash ended the quarter at $158.5 million. Total debt stood at about $2.53 billion, including term loans and three series of senior notes. The company operates 275 facilities with roughly 12,400 beds and continues to invest in growth through new beds, joint ventures and de novo facilities.
Acadia Healthcare (ACHC) reported Q3 2025 results with revenue of $851.6 million, up from $815.6 million a year ago. Net income attributable to the company was $36.2 million versus $68.1 million last year, and diluted EPS was $0.40 versus $0.74.
Year to date, operating cash flow reached $218.2 million. The company invested $478.6 million in capital expenditures and ended the quarter with cash of $118.7 million. Q3 “transaction, legal and other costs” were $42.9 million, including $38.7 million for government investigations. Payor mix remained weighted to Medicaid at 56.9% in the quarter.
Acadia refinanced its debt with a new Credit Facility comprising a $1.0 billion revolver and a $650.0 million term loan maturing in 2030, and issued $550.0 million of 7.375% Senior Notes due 2033, contributing to long‑term debt of $2.285 billion at quarter‑end. Under its $300.0 million share repurchase program authorized in 2025, the company bought back 1,706,625 shares for $50.4 million, leaving $250.0 million available.